201 related articles for article (PubMed ID: 28591790)
41. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar.
Lee J; Kim TI; Kang JM; Jun H; Lê HG; Thái TL; Sohn WM; Myint MK; Lin K; Kim TS; Na BK
BMC Infect Dis; 2018 Mar; 18(1):131. PubMed ID: 29548282
[TBL] [Abstract][Full Text] [Related]
42. Performance of a Commercial Multiplex Allele-Specific Polymerase Chain Reaction Kit to Genotype African-Type Glucose-6-Phosphate Dehydrogenase Deficiency.
Djigo OKM; Gomez N; Ould Ahmedou Salem MS; Basco L; Ould Mohamed Salem Boukhary A; Briolant S
Am J Trop Med Hyg; 2023 Feb; 108(2):449-455. PubMed ID: 36535256
[TBL] [Abstract][Full Text] [Related]
43. A Way Forward for Culturing Plasmodium vivax.
Gunalan K; Rowley EH; Miller LH
Trends Parasitol; 2020 Jun; 36(6):512-519. PubMed ID: 32360314
[TBL] [Abstract][Full Text] [Related]
44. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
45. A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum.
Rumaseb A; Marfurt J; Kho S; Kahn M; Price RN; Ley B
BMC Res Notes; 2022 Feb; 15(1):76. PubMed ID: 35193663
[TBL] [Abstract][Full Text] [Related]
46. [Role of primaquine in malaria control and elimination in French-speaking Africa].
Briolant S; Pradines B; Basco LK
Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
[TBL] [Abstract][Full Text] [Related]
47. Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients.
Kotepui M; Uthaisar K; PhunPhuech B; Phiwklam N
Infect Dis Poverty; 2016 Apr; 5():36. PubMed ID: 27109515
[TBL] [Abstract][Full Text] [Related]
48. Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago.
Kaneko A; Taleo G; Kalkoa M; Yaviong J; Reeve PA; Ganczakowski M; Shirakawa C; Palmer K; Kobayakawa T; Björkman A
Acta Trop; 1998 Jul; 70(3):285-302. PubMed ID: 9777715
[TBL] [Abstract][Full Text] [Related]
49. Glucose-6-Phosphate Dehydrogenase Deficiency Genetic Variants in Malaria Patients in Southwestern Ethiopia.
Carter TE; Mekonnen SK; Lopez K; Bonnell V; Damodaran L; Aseffa A; Janies DA
Am J Trop Med Hyg; 2018 Jan; 98(1):83-87. PubMed ID: 29141760
[TBL] [Abstract][Full Text] [Related]
50. Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency.
Chamchod F; Beier JC
J Theor Biol; 2013 Jan; 316():25-34. PubMed ID: 22959914
[TBL] [Abstract][Full Text] [Related]
51. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
Malar J; 2016 Feb; 15():82. PubMed ID: 26864333
[TBL] [Abstract][Full Text] [Related]
52. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
[TBL] [Abstract][Full Text] [Related]
53. Implementation of G6PD testing and primaquine for
Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
[TBL] [Abstract][Full Text] [Related]
54. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency.
Baird JK
BMC Med; 2015 Dec; 13():296. PubMed ID: 26652887
[TBL] [Abstract][Full Text] [Related]
55. Seven different glucose-6-phosphate dehydrogenase variants including a new variant distributed in Lam Dong Province in southern Vietnam.
Matsuoka H; Thuan DT; van Thien H; Kanbe T; Jalloh A; Hirai M; Arai M; Dung NT; Kawamoto F
Acta Med Okayama; 2007 Aug; 61(4):213-9. PubMed ID: 17726510
[TBL] [Abstract][Full Text] [Related]
56. Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.
Baird JK; Battle KE; Howes RE
Malar J; 2018 Jan; 17(1):42. PubMed ID: 29357870
[TBL] [Abstract][Full Text] [Related]
57. Glucose-6-phosphate dehydrogenase polymorphisms and susceptibility to mild malaria in Dogon and Fulani, Mali.
Maiga B; Dolo A; Campino S; Sepulveda N; Corran P; Rockett KA; Troye-Blomberg M; Doumbo OK; Clark TG
Malar J; 2014 Jul; 13():270. PubMed ID: 25015414
[TBL] [Abstract][Full Text] [Related]
58. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
[TBL] [Abstract][Full Text] [Related]
59. A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax.
Russell B; Suwanarusk R; Borlon C; Costa FT; Chu CS; Rijken MJ; Sriprawat K; Warter L; Koh EG; Malleret B; Colin Y; Bertrand O; Adams JH; D'Alessandro U; Snounou G; Nosten F; Rénia L
Blood; 2011 Sep; 118(13):e74-81. PubMed ID: 21768300
[TBL] [Abstract][Full Text] [Related]
60. Effect of neonatal reticulocytosis on glucose 6-phosphate dehydrogenase (G6PD) activity and G6PD deficiency detection: a cross-sectional study.
Pimpakan T; Mungkalasut P; Tansakul P; Chanda M; Jugnam-Ang W; Charucharana S; Cheepsunthorn P; Fucharoen S; Punnahitananda S; Cheepsunthorn CL
BMC Pediatr; 2022 Nov; 22(1):678. PubMed ID: 36419023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
